Merus Labs International Inc. Co (MSLI) 1.96 $MSLI
Merus Labs misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 3:46PM CST
MSLI: 1.96 (+0.08)
Merus Labs Announces Record Q1 2015 Results
Marketwired - Wed Feb 11, 3:02PM CST
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results for its first quarter of fiscal year 2015.
MSLI: 1.96 (+0.08)
IIROC Trade Resumption - MSL
CNW Group - Fri Feb 06, 2:52PM CST
Trading resumes in:
MSLI: 1.96 (+0.08)
IIROC Trading Halt - MSL
CNW Group - Fri Feb 06, 2:46PM CST
The following issues have been halted by IIROC:
MSLI: 1.96 (+0.08)
IIROC Trade Resumption - Merus Labs International Inc.
Newsfile Corp - Fri Feb 06, 2:37PM CST
Trading resumes in:
MSLI: 1.96 (+0.08)
IIROC Trade Halt - Merus Labs International Inc.
Newsfile Corp - Fri Feb 06, 2:35PM CST
The following issues have been halted by IIROC:
MSLI: 1.96 (+0.08)
Merus Labs Appoints Geoff Morrow as Vice President, Business Development
Marketwired - Wed Feb 04, 7:03AM CST
Merus Labs International Inc. (TSX: MSL)(NASDAQ: MSLI) ("Merus" or "the Company" today announced the appointment of Geoff Morrow as Vice President, Business Development.
MSL.TO: 2.43 (+0.13), MSLI: 1.96 (+0.08)
FDA clears Daiichi-Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 6:55PM CST
PTLA: 34.96 (+3.13), PFE: 34.64 (-0.23), BMY: 60.04 (+0.56), JNJ: 99.62 (+1.18), ISIS: 63.86 (-0.43), MDCO: 29.79 (+0.91), BAX: 70.39 (+0.31), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07), SCLN: 7.85 (+0.08), MSLI: 1.96 (+0.08)
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
Life Sciences Report - Seeking Alpha - Fri Dec 19, 9:53AM CST
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences...
BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), QLTI: 4.15 (unch), CTRX: 53.24 (+0.65), BCRX: 10.06 (-0.09), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), TKMR: 21.45 (-0.22), NEPT: 1.83 (+0.06), BSX: 14.98 (+0.24), AGN: 229.49 (+1.87), CMRX: 40.16 (+0.08), ALNY: 95.54 (+1.67), SRPT: 12.76 (+0.11), SHPG: 239.82 (+6.11), NLNK: 38.84 (+1.51), SNY: 49.42 (+0.82), MSLI: 1.96 (+0.08), NVCN: 9.08 (-0.17), CRME: 9.76 (-0.14), EBS: 28.76 (-0.12), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), NVDQ: 15.12 (+0.51), NVS: 102.20 (-0.17)
Merus Labs International Inc. Announces Results for Fiscal 2014
Marketwired - Thu Dec 18, 3:01PM CST
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results for its fiscal year 2014.
MSLI: 1.96 (+0.08)
Merus chief drops the "interim" tag
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 3:43PM CST
MSLI: 1.96 (+0.08)
Merus Labs International Inc. Appoints Barry Fishman as Chief Executive Officer
Marketwired - Mon Dec 15, 2:00PM CST
The Board of Directors of Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) is pleased to announce the appointment of Mr. Barry Fishman as CEO, effective today. Mr. Fishman has been serving as interim CEO since September 23, 2014.
MSL.TO: 2.43 (+0.13), MSLI: 1.96 (+0.08)
Merus Labs International Inc. Announces Normal Course Issuer Bid
Marketwire Canada - Mon Nov 17, 7:00AM CST
Merus Labs International Inc. ("Merus" or the "Company" (TSX:MSL)(NASDAQ:MSLI) announced today that it is proceeding with a normal course issuer bid for up to 7,615,972 common shares of the Company, representing approximately 10% of the total public float of the common shares of the Company. On November 12, 2014, the Company had a total of 81,245,724 common shares outstanding out of which a total of 5,086,000 common shares are non-public shares held by directors and senior officers or held in escrow. The Company has received approval from the Toronto Stock Exchange (the "TSX" to commence this bid on November 19, 2014. Purchases will be made on the TSX at the market price at the time of acquisition. Pursuant to TSX policies, daily purchases will not exceed 149,025 common shares except where such purchases are made in accordance with "block purchases" exemptions under applicable TSX policies.
MSL.TO: 2.43 (+0.13), MSLI: 1.96 (+0.08)
Merus Labs International Inc (MSLI) Downgraded From Hold to Sell
at The Street - Tue Oct 28, 8:46AM CDT
Merus Labs International Inc (MSLI) has been downgraded by TheStreet Ratings from Hold to Sell with a ratings score of D+.
MSLI: 1.96 (+0.08)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 11:47AM CDT
NPD: 1.55 (+0.06), IMDZ: 25.34 (+1.20), BCRX: 10.06 (-0.09), DLHC: 2.21 (-0.06), SWSH: 2.07 (-0.03), VSR: 3.42 (-0.02), PPHM: 1.28 (+0.03), EVRY: 1.00 (-0.04), DYNT: 3.36 (-0.21), NBG: 1.61 (+0.18), AMDA: 0.65 (+0.01), TRCH: 0.53 (-0.01), KTCC: 9.70 (-0.05), APT: 2.88 (+0.17), SHPG: 239.82 (+6.11), PENX: 18.87 (-0.01), LAKE: 10.18 (+0.89), MSLI: 1.96 (+0.08), COVS: 2.47 (+0.11)
Merus Labs Announces Management & Board Changes
Marketwire - Tue Sep 23, 6:31AM CDT
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) today announced that Mr. Elie Farah has resigned as CEO and as a member of the Merus Board to pursue other opportunities. The Board of Directors thanks Mr. Farah for his contribution to building a strong foundation and platform for growth for the Company and wishes him well in his future endeavors.
MSLI: 1.96 (+0.08)
Merus Labs misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 3:46PM CST
MSLI: 1.96 (+0.08)
Merus Labs Announces Record Q1 2015 Results
Marketwired - Wed Feb 11, 3:02PM CST
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results for its first quarter of fiscal year 2015. MSLI: 1.96 (+0.08)
IIROC Trade Resumption - MSL
CNW Group - Fri Feb 06, 2:52PM CST
Trading resumes in:
MSLI: 1.96 (+0.08)
IIROC Trading Halt - MSL
CNW Group - Fri Feb 06, 2:46PM CST
The following issues have been halted by IIROC:
MSLI: 1.96 (+0.08)
IIROC Trade Resumption - Merus Labs International Inc.
Newsfile Corp - Fri Feb 06, 2:37PM CST
Trading resumes in:
MSLI: 1.96 (+0.08)
IIROC Trade Halt - Merus Labs International Inc.
Newsfile Corp - Fri Feb 06, 2:35PM CST
The following issues have been halted by IIROC:
MSLI: 1.96 (+0.08)
Merus Labs Appoints Geoff Morrow as Vice President, Business Development
Marketwired - Wed Feb 04, 7:03AM CST
Merus Labs International Inc. (TSX: MSL)(NASDAQ: MSLI) ("Merus" or "the Company"
today announced the appointment of Geoff Morrow as Vice President, Business Development. MSL.TO: 2.43 (+0.13), MSLI: 1.96 (+0.08)
FDA clears Daiichi-Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 6:55PM CST
PTLA: 34.96 (+3.13), PFE: 34.64 (-0.23), BMY: 60.04 (+0.56), JNJ: 99.62 (+1.18), ISIS: 63.86 (-0.43), MDCO: 29.79 (+0.91), BAX: 70.39 (+0.31), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07), SCLN: 7.85 (+0.08), MSLI: 1.96 (+0.08)
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
Life Sciences Report - Seeking Alpha - Fri Dec 19, 9:53AM CST
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences...
BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), QLTI: 4.15 (unch), CTRX: 53.24 (+0.65), BCRX: 10.06 (-0.09), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), TKMR: 21.45 (-0.22), NEPT: 1.83 (+0.06), BSX: 14.98 (+0.24), AGN: 229.49 (+1.87), CMRX: 40.16 (+0.08), ALNY: 95.54 (+1.67), SRPT: 12.76 (+0.11), SHPG: 239.82 (+6.11), NLNK: 38.84 (+1.51), SNY: 49.42 (+0.82), MSLI: 1.96 (+0.08), NVCN: 9.08 (-0.17), CRME: 9.76 (-0.14), EBS: 28.76 (-0.12), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), NVDQ: 15.12 (+0.51), NVS: 102.20 (-0.17)
Merus Labs International Inc. Announces Results for Fiscal 2014
Marketwired - Thu Dec 18, 3:01PM CST
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results for its fiscal year 2014. MSLI: 1.96 (+0.08)
Merus chief drops the "interim" tag
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 3:43PM CST
MSLI: 1.96 (+0.08)
Merus Labs International Inc. Appoints Barry Fishman as Chief Executive Officer
Marketwired - Mon Dec 15, 2:00PM CST
The Board of Directors of Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce the appointment of Mr. Barry Fishman as CEO, effective today. Mr. Fishman has been serving as interim CEO since September 23, 2014. MSL.TO: 2.43 (+0.13), MSLI: 1.96 (+0.08)
Merus Labs International Inc. Announces Normal Course Issuer Bid
Marketwire Canada - Mon Nov 17, 7:00AM CST
Merus Labs International Inc. ("Merus" or the "Company"
(TSX:MSL)(NASDAQ:MSLI) announced today that it is proceeding with a normal course issuer bid for up to 7,615,972 common shares of the Company, representing approximately 10% of the total public float of the common shares of the Company. On November 12, 2014, the Company had a total of 81,245,724 common shares outstanding out of which a total of 5,086,000 common shares are non-public shares held by directors and senior officers or held in escrow. The Company has received approval from the Toronto Stock Exchange (the "TSX" to commence this bid on November 19, 2014. Purchases will be made on the TSX at the market price at the time of acquisition. Pursuant to TSX policies, daily purchases will not exceed 149,025 common shares except where such purchases are made in accordance with "block purchases" exemptions under applicable TSX policies. MSL.TO: 2.43 (+0.13), MSLI: 1.96 (+0.08)
Merus Labs International Inc (MSLI) Downgraded From Hold to Sell
at The Street - Tue Oct 28, 8:46AM CDT
Merus Labs International Inc (MSLI) has been downgraded by TheStreet Ratings from Hold to Sell with a ratings score of D+.
MSLI: 1.96 (+0.08)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 11:47AM CDT
NPD: 1.55 (+0.06), IMDZ: 25.34 (+1.20), BCRX: 10.06 (-0.09), DLHC: 2.21 (-0.06), SWSH: 2.07 (-0.03), VSR: 3.42 (-0.02), PPHM: 1.28 (+0.03), EVRY: 1.00 (-0.04), DYNT: 3.36 (-0.21), NBG: 1.61 (+0.18), AMDA: 0.65 (+0.01), TRCH: 0.53 (-0.01), KTCC: 9.70 (-0.05), APT: 2.88 (+0.17), SHPG: 239.82 (+6.11), PENX: 18.87 (-0.01), LAKE: 10.18 (+0.89), MSLI: 1.96 (+0.08), COVS: 2.47 (+0.11)
Merus Labs Announces Management & Board Changes
Marketwire - Tue Sep 23, 6:31AM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) today announced that Mr. Elie Farah has resigned as CEO and as a member of the Merus Board to pursue other opportunities. The Board of Directors thanks Mr. Farah for his contribution to building a strong foundation and platform for growth for the Company and wishes him well in his future endeavors. MSLI: 1.96 (+0.08)
